Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03508271 · ClinicalTrials.gov registry record
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
A clinical trial of Heart Failure and Atrial Fibrillation, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 60,000
- Enrollment target
- 1
- Study location
NCT03508271: Completed study of Heart Failure and Atrial Fibrillation, sponsored by Bristol-Myers Squibb.
NCT03508271 is a study of Heart Failure and Atrial Fibrillation that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 60,000 participants, above the 1,898-participant average among 397 other Heart Failure trials with a reported enrollment target (3061% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03508271, a study of Heart Failure and Atrial Fibrillation, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 60,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
Conditions Studied
Interventions
- OTHER Non-Interventional
Study Locations (1)
Michigan
- Local Institution - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2018-11-08 |
What the finished NCT03508271 record still lists
NCT03508271 is an observational study that tracks outcomes without assigning an intervention. Its 60,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,898-participant average among 397 other Heart Failure trials with a reported enrollment target (3061% higher).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional is the first listed.
NCT03508271 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03508271 about?
NCT03508271 is a clinical study titled "Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure". Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
What is the current status of trial NCT03508271?
This trial is currently completed. The enrollment target is 60,000 participants. The study started on 2017-11-30. Estimated completion is 2018-11-08.
What conditions does trial NCT03508271 study?
This clinical trial studies the following conditions: Heart Failure, Atrial Fibrillation.
What interventions are being tested in trial NCT03508271?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT03508271?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03508271 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03508271's enrollment target sits among peer trials
60,000 3rd of 397 higher than 395 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI